Kronox Lab Sciences

Kronox Lab Sciences EBITDA per Share

The EBITDA per Share of Kronox Lab Sciences (KRONOX.NS) as of Nov 3, 2026 is 10.08 INR. In the previous year, EBITDA per Share was 9.12 INR — a change of 10.56% (higher).

EBITDA per Share

10.08INR

YoY

10.56%

Last updated:

EBITDA per Share of Kronox Lab Sciences is 2026 10.08 INR. EBITDA per Share of Kronox Lab Sciences was 2025 9.12 INR. It decreases by 10.56% higher compared to the previous year.

The Kronox Lab Sciences EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2022
5.06 INR
Jan 1, 2023
5.93 INR
Jan 1, 2024
7.77 INR
Jan 1, 2025
9.12 INR
Jan 1, 2026
10.08 INR
The Kronox Lab Sciences EBITDA per Share history
YEAREBITDA per ShareYoY
10.08INR+10.56%
9.12INR+17.39%
7.77INR+31.07%
5.93INR+17.26%
5.06INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kronox Lab Sciences Stock analysis

What does Kronox Lab Sciences do? Kronox Lab Sciences Pvt.Ltd manufactures high purity fine chemicals for pharmaceutical, nutraceutical, veterinary, food, chemical analysis, and specialty markets. The company offers products including acetates, carbonates, chlorides, citrates, hypophosphites, nitrates, nitrites, phosphates, sulfates, and ultra-pure metallic salts. Their product range features ACS Reagent, LR, AR, and GR Reagents, Oral Care, Pharmacopoeia, Food and Nutraceutical, Personal Care and Cosmetics, Veterinary Pharma and Animal Health, Tartrates, Citrates, Hypophosphites, Phosphates, Hydroxides, EDTA and Derivatives, Ultra High Purity Chemicals, Custom Specification, and Specialty Anhydrous. The firm produces these chemicals in particle sizes from 10 mesh to 100 mesh for bulk manufacturing. The company serves pharmaceutical, nutraceutical, veterinary, food, and chemical analysis sectors through its high purity fine chemicals. Customers include manufacturers requiring ACS Reagent, LR, AR, and GR Reagents for laboratory and industrial use, as well as those needing specialized products like EDTA and Derivatives for pharmaceutical applications. The firm targets specialty markets demanding ultra-high purity standards, particularly in pharmaceutical and veterinary pharma segments. Kronox Lab Sciences Pvt.Ltd generates revenue by supplying bulk quantities of high purity fine chemicals to industries requiring precise chemical specifications. Their product portfolio caters to multiple segments including pharmaceutical, nutraceutical, veterinary, food, and chemical analysis, with a focus on ultra-high purity and custom specifications. The company's manufacturing capabilities in particle sizes from 10 mesh to 100 mesh support diverse industrial applications across these markets. Kronox Lab Sciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kronox Lab Sciences stock

EBITDA per Share of Kronox Lab Sciences is 10.08 INR in 2026.

EBITDA per Share of Kronox Lab Sciences changed from 9.12 INR to 10.08 INR, representing a 10.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Kronox Lab Sciences since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Kronox Lab Sciences

All Key Metrics — Kronox Lab Sciences